• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

负载于介孔二氧化硅MCM-41中的辛伐他汀存在强烈客体-主体相互作用的证据。

Evidence of Strong Guest-Host Interactions in Simvastatin Loaded in Mesoporous Silica MCM-41.

作者信息

Cordeiro Teresa, Matos Inês, Danède Florence, Sotomayor João C, Fonseca Isabel M, Corvo Marta C, Dionísio Madalena, Viciosa María Teresa, Affouard Frédéric, Correia Natália T

机构信息

LAQV-REQUIMTE, Department of Chemistry, NOVA School of Science and Technology, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal.

Univ. Lille, CNRS, INRAE, Centrale Lille, UMR 8207 - UMET - Unité Matériaux et Transformations, F-59000 Lille, France.

出版信息

Pharmaceutics. 2023 Apr 22;15(5):1320. doi: 10.3390/pharmaceutics15051320.

DOI:10.3390/pharmaceutics15051320
PMID:37242562
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10222570/
Abstract

A rational design of drug delivery systems requires in-depth knowledge not only of the drug itself, in terms of physical state and molecular mobility, but also of how it is distributed among a carrier and its interactions with the host matrix. In this context, this work reports the behavior of simvastatin (SIM) loaded in mesoporous silica MCM-41 matrix (average pore diameter ~3.5 nm) accessed by a set of experimental techniques, evidencing that it exists in an amorphous state (X-ray diffraction, ssNMR, ATR-FTIR, and DSC). The most significant fraction of SIM molecules corresponds to a high thermal resistant population, as shown by thermogravimetry, and which interacts strongly with the MCM silanol groups, as revealed by ATR-FTIR analysis. These findings are supported by Molecular Dynamics (MD) simulations predicting that SIM molecules anchor to the inner pore wall through multiple hydrogen bonds. This anchored molecular fraction lacks a calorimetric and dielectric signature corresponding to a dynamically rigid population. Furthermore, differential scanning calorimetry showed a weak glass transition that is shifted to lower temperatures compared to bulk amorphous SIM. This accelerated molecular population is coherent with an in-pore fraction of molecules distinct from bulklike SIM, as highlighted by MD simulations. MCM-41 loading proved to be a suitable strategy for a long-term stabilization (at least three years) of simvastatin in the amorphous form, whose unanchored population releases at a much higher rate compared to the crystalline drug dissolution. Oppositely, the surface-attached molecules are kept entrapped inside pores even after long-term release assays.

摘要

药物递送系统的合理设计不仅需要深入了解药物本身的物理状态和分子流动性,还需要了解其在载体中的分布情况以及与宿主基质的相互作用。在此背景下,本工作报道了通过一系列实验技术研究辛伐他汀(SIM)负载于介孔二氧化硅MCM - 41基质(平均孔径约3.5 nm)中的行为,证明其以非晶态存在(X射线衍射、固体核磁共振、衰减全反射傅里叶变换红外光谱和差示扫描量热法)。热重分析表明,SIM分子中最主要的部分对应于高热稳定性群体,衰减全反射傅里叶变换红外光谱分析显示其与MCM硅醇基团强烈相互作用。分子动力学(MD)模拟预测SIM分子通过多个氢键锚定在内孔壁上,支持了这些发现。这种锚定的分子部分缺乏对应于动态刚性群体的量热和介电特征。此外,差示扫描量热法显示出较弱的玻璃化转变,与块状非晶态SIM相比,其转变温度向低温偏移。如MD模拟所强调的,这种加速的分子群体与不同于块状SIM的孔内分子部分一致。事实证明,MCM - 41负载是将辛伐他汀长期稳定在非晶态(至少三年)的合适策略,其未锚定的群体释放速率比结晶药物溶解速率高得多。相反,即使经过长期释放试验,表面附着的分子仍被困在孔内。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/3ed6b7e202c3/pharmaceutics-15-01320-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/b49e0d81fe39/pharmaceutics-15-01320-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/ea810db951be/pharmaceutics-15-01320-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/f241fd297f3f/pharmaceutics-15-01320-g0A3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/c4dbc939af57/pharmaceutics-15-01320-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/2e80b3c4ae36/pharmaceutics-15-01320-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/e9895547357f/pharmaceutics-15-01320-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/13975e137920/pharmaceutics-15-01320-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/184477fa27a4/pharmaceutics-15-01320-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/547fccfb6371/pharmaceutics-15-01320-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/08fcde07dbf8/pharmaceutics-15-01320-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/04e543f2d15c/pharmaceutics-15-01320-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/9585fce02918/pharmaceutics-15-01320-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/82b9713818a3/pharmaceutics-15-01320-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/12a7dfb68ae2/pharmaceutics-15-01320-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/fac922887d18/pharmaceutics-15-01320-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/797e88a038a8/pharmaceutics-15-01320-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/3ed6b7e202c3/pharmaceutics-15-01320-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/b49e0d81fe39/pharmaceutics-15-01320-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/ea810db951be/pharmaceutics-15-01320-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/f241fd297f3f/pharmaceutics-15-01320-g0A3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/c4dbc939af57/pharmaceutics-15-01320-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/2e80b3c4ae36/pharmaceutics-15-01320-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/e9895547357f/pharmaceutics-15-01320-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/13975e137920/pharmaceutics-15-01320-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/184477fa27a4/pharmaceutics-15-01320-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/547fccfb6371/pharmaceutics-15-01320-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/08fcde07dbf8/pharmaceutics-15-01320-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/04e543f2d15c/pharmaceutics-15-01320-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/9585fce02918/pharmaceutics-15-01320-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/82b9713818a3/pharmaceutics-15-01320-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/12a7dfb68ae2/pharmaceutics-15-01320-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/fac922887d18/pharmaceutics-15-01320-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/797e88a038a8/pharmaceutics-15-01320-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/10222570/3ed6b7e202c3/pharmaceutics-15-01320-sch002.jpg

相似文献

1
Evidence of Strong Guest-Host Interactions in Simvastatin Loaded in Mesoporous Silica MCM-41.负载于介孔二氧化硅MCM-41中的辛伐他汀存在强烈客体-主体相互作用的证据。
Pharmaceutics. 2023 Apr 22;15(5):1320. doi: 10.3390/pharmaceutics15051320.
2
How Molecular Mobility, Physical State, and Drug Distribution Influence the Naproxen Release Profile from Different Mesoporous Silica Matrices.分子迁移率、物理状态和药物分布如何影响不同介孔硅基质中萘普生的释放特性。
Mol Pharm. 2021 Mar 1;18(3):898-914. doi: 10.1021/acs.molpharmaceut.0c00908. Epub 2021 Jan 18.
3
Characterising glass transition temperatures and glass dynamics in mesoporous silica-based amorphous drugs.表征介孔硅基无定形药物中的玻璃化转变温度和玻璃动力学。
Phys Chem Chem Phys. 2019 Sep 11;21(35):19686-19694. doi: 10.1039/c9cp01764j.
4
Experimental, Thermodynamic, and Molecular Modeling Evaluation of Amorphous Simvastatin-Poly(vinylpyrrolidone) Solid Dispersions.实验、热力学和分子模拟评估辛伐他汀-聚乙烯吡咯烷酮无定形固体分散体。
Mol Pharm. 2020 Jul 6;17(7):2703-2720. doi: 10.1021/acs.molpharmaceut.0c00413. Epub 2020 Jun 22.
5
Stabilizing Unstable Amorphous Menthol through Inclusion in Mesoporous Silica Hosts.通过包埋在介孔硅载体中稳定非晶态薄荷醇。
Mol Pharm. 2017 Sep 5;14(9):3164-3177. doi: 10.1021/acs.molpharmaceut.7b00386. Epub 2017 Aug 24.
6
Characterization of Drugs with Good Glass Formers in Loaded-Mesoporous Silica and Its Theoretical Value Relevance with Mesopores Surface and Pore-Filling Capacity.负载型介孔二氧化硅中具有良好玻璃形成剂的药物表征及其与介孔表面和孔填充能力的理论值相关性
Pharmaceuticals (Basel). 2022 Jan 13;15(1):93. doi: 10.3390/ph15010093.
7
Ordered nanoporous silica as carriers for improved delivery of water insoluble drugs: a comparative study between three dimensional and two dimensional macroporous silica.有序纳米孔硅作为载体提高难溶性药物的递送:三维和二维大孔硅的比较研究。
Int J Nanomedicine. 2013;8:4015-31. doi: 10.2147/IJN.S52605. Epub 2013 Oct 22.
8
Highly ordered mesoporous carbon nanomatrix as a new approach to improve the oral absorption of the water-insoluble drug, simvastatin.高度有序的介孔碳纳米基质作为一种提高难溶性药物辛伐他汀口服吸收的新方法。
Eur J Pharm Sci. 2013 Aug 16;49(5):864-72. doi: 10.1016/j.ejps.2013.05.031. Epub 2013 Jun 18.
9
Preparation of Solid Dispersions of Simvastatin and Soluplus Using a Single-Step Organic Solvent-Free Supercritical Fluid Process for the Drug Solubility and Dissolution Rate Enhancement.采用一步法无有机溶剂超临界流体工艺制备辛伐他汀与 Soluplus 的固体分散体以提高药物溶解度和溶出速率
Pharmaceuticals (Basel). 2021 Aug 25;14(9):846. doi: 10.3390/ph14090846.
10
Nanostructure-loaded mesoporous silica for controlled release of coumarin derivatives: a novel testing of the hyperthermia effect.载药介孔硅纳米结构用于香豆素衍生物的控制释放:一种新型的热疗效果测试。
Eur J Pharm Biopharm. 2011 Jan;77(1):66-74. doi: 10.1016/j.ejpb.2010.10.007. Epub 2010 Oct 23.

引用本文的文献

1
Influence of Pore Size of Mesoporous Silica on Physical Stability of Overloaded Celecoxib Glass.介孔二氧化硅孔径对超量塞来昔布玻璃物理稳定性的影响。
Mol Pharm. 2025 May 5;22(5):2556-2567. doi: 10.1021/acs.molpharmaceut.4c01482. Epub 2025 Apr 4.
2
Understanding Fenofibrate Release from Bare and Modified Mesoporous Silica Nanoparticles.了解非诺贝特从裸露和改性介孔二氧化硅纳米颗粒中的释放情况。
Pharmaceutics. 2023 May 30;15(6):1624. doi: 10.3390/pharmaceutics15061624.

本文引用的文献

1
Hyaluronic Acid-Functionalized Mesoporous Silica Nanoparticles Loading Simvastatin for Targeted Therapy of Atherosclerosis.负载辛伐他汀的透明质酸功能化介孔二氧化硅纳米粒子用于动脉粥样硬化的靶向治疗
Pharmaceutics. 2022 Jun 14;14(6):1265. doi: 10.3390/pharmaceutics14061265.
2
Formulation and Biological Evaluation of Mesoporous Silica Nanoparticles Loaded with Combinations of Sortase A Inhibitors and Antimicrobial Peptides.负载分选酶A抑制剂与抗菌肽组合的介孔二氧化硅纳米颗粒的制剂及生物学评价
Pharmaceutics. 2022 May 4;14(5):986. doi: 10.3390/pharmaceutics14050986.
3
Structural and Dynamical Properties of Liquids in Confinements: A Review of Molecular Dynamics Simulation Studies.
受限液体的结构与动力学性质:分子动力学模拟研究综述
Langmuir. 2022 May 31;38(21):6506-6522. doi: 10.1021/acs.langmuir.2c00521. Epub 2022 May 17.
4
Preparation of Solid Dispersions of Simvastatin and Soluplus Using a Single-Step Organic Solvent-Free Supercritical Fluid Process for the Drug Solubility and Dissolution Rate Enhancement.采用一步法无有机溶剂超临界流体工艺制备辛伐他汀与 Soluplus 的固体分散体以提高药物溶解度和溶出速率
Pharmaceuticals (Basel). 2021 Aug 25;14(9):846. doi: 10.3390/ph14090846.
5
Fabrication and Appraisal of Simvastatin via Tailored Niosomal Nanovesicles for Transdermal Delivery Enhancement: In Vitro and In Vivo Assessment.通过定制的囊泡纳米囊泡制备辛伐他汀以增强透皮给药:体外和体内评估
Pharmaceutics. 2021 Jan 21;13(2):138. doi: 10.3390/pharmaceutics13020138.
6
How Molecular Mobility, Physical State, and Drug Distribution Influence the Naproxen Release Profile from Different Mesoporous Silica Matrices.分子迁移率、物理状态和药物分布如何影响不同介孔硅基质中萘普生的释放特性。
Mol Pharm. 2021 Mar 1;18(3):898-914. doi: 10.1021/acs.molpharmaceut.0c00908. Epub 2021 Jan 18.
7
Microfluidics Used as a Tool to Understand and Optimize Membrane Filtration Processes.微流控技术作为理解和优化膜过滤过程的工具
Membranes (Basel). 2020 Oct 29;10(11):316. doi: 10.3390/membranes10110316.
8
Understanding Concomitant Physical and Chemical Transformations of Simvastatin During Dry Ball Milling.理解辛伐他汀在干法球磨过程中的伴随物理和化学变化。
AAPS PharmSciTech. 2020 May 21;21(5):152. doi: 10.1208/s12249-020-01687-z.
9
Importance of Mesoporous Silica Particle Size in the Stabilization of Amorphous Pharmaceuticals-The Case of Simvastatin.介孔二氧化硅粒径对无定形药物(以辛伐他汀为例)稳定性的重要性
Pharmaceutics. 2020 Apr 22;12(4):384. doi: 10.3390/pharmaceutics12040384.
10
Silica-Polymer Composites as the Novel Antibiotic Delivery Systems for Bone Tissue Infection.二氧化硅-聚合物复合材料作为骨组织感染的新型抗生素递送系统
Pharmaceutics. 2019 Dec 30;12(1):28. doi: 10.3390/pharmaceutics12010028.